Levetiracetam Altan

Levetiracetam, the active ingredient in Levetiracetam Altan, is an anticonvulsant presented as an intravenous solution for intravenous use. It is employed to control various seizure types in patients diagnosed with epilepsy. GNH USA supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic agent that modulates neuronal excitability to reduce seizure activity. - Partial‑onset seizures: helps achieve seizure control in focal epilepsy. - Generalized tonic‑clonic seizures: contributes to reduction of convulsive episodes. - Myoclonic seizures: assists in decreasing sudden muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: generalized feeling of tiredness. - Headache: mild to moderate cranial pain. - Somnolence: increased sleepiness or drowsiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Suicidal thoughts or behavior: emergence of mood changes or depressive symptoms.

Before initiating therapy, clinicians should consider several safety aspects. - Renal function monitoring: adjust dose in patients with impaired clearance. - Psychiatric assessment: watch for mood changes or suicidal ideation. - Concomitant CNS depressants: avoid excessive sedation. - Abrupt discontinuation: taper to prevent seizure worsening. - Hepatic disease caution: use with clinical judgment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam has a relatively low interaction profile, yet certain combinations require attention.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam levels. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Sedative agents (e.g., benzodiazepines): additive sedative effect. - Probenecid: may increase levetiracetam levels by reducing renal excretion.